Prolonged beneficial effect of bosentan treatment and 4-year survival rates in adult patients with pulmonary arterial hypertension associated with congenital heart disease.

Vis, Jeroen C

Prolonged beneficial effect of bosentan treatment and 4-year survival rates in adult patients with pulmonary arterial hypertension associated with congenital heart disease. [electronic resource] - International journal of cardiology Mar 2013 - 64-9 p. digital

Publication Type: Journal Article

1874-1754

10.1016/j.ijcard.2011.06.064 doi


Adult
Antihypertensive Agents--therapeutic use
Bosentan
Down Syndrome--complications
Familial Primary Pulmonary Hypertension
Female
Heart Defects, Congenital--complications
Humans
Hypertension, Pulmonary--complications
Male
Middle Aged
Sulfonamides--therapeutic use
Survival Rate
Time Factors